Werfen

Founded in 1966, Werfen has emerged as a global leader in the development, distribution, and support of in vitro diagnostic systems. The company is headquartered in Barcelona, Spain, and is dedicated to delivering innovative solutions in the healthcare sector. With a strong focus on scientific advancement, Werfen provides essential medical devices and clinical software solutions that enhance patient care and operational efficiency in healthcare facilities worldwide.

Werfen's portfolio is centred around specialised areas such as haemostasis, blood gas analysis, and autoimmunity. Through its commitment to research and development, the company continues to pioneer advancements that meet the evolving needs of the healthcare industry. By partnering with clinicians and healthcare institutions, Werfen ensures its solutions are aligned with real-world requirements and deliver measurable improvements in patient outcomes.

Employing over 7,100 individuals globally, Werfen has built a robust network of operations and support to maintain its status as a trusted partner in the medical field. The leadership under CEO Carlos Pascual drives a culture of excellence and innovation, which is reflected in the company's steady growth and significant revenue generation. As healthcare continues to evolve, Werfen remains dedicated to advancing scientific knowledge and improving diagnostic capabilities on a global scale.